Flexner and Lewis (1), in connection with their studies of the protective and therapeutic powers of convalescent serum in experimental poliomyelitis, employed the method of reinoculation of virus in recovered monkeys to increase the strength or potency of this serum. The procedure was largely empirical, as no actual quantitative estimations of neutralizing action before and after the reinoculations were made. The impression gained, however, was that reinoculation did increase the potency of the sermn.
Monkey immune serm~ as now employed for experimental purposes may be considered to be of two sorts: convalescent serum in the true sense, and serum derived from monkeys actively immunized with virus introduced by various routes without symptoms of infection appearing at any time. In practical experiments, little or no distinction has been made between these two kinds of immune sera, and no exact quantitative neutralization comparisons have been carried out. Stewart and Rhoads (2) have, however, shown thatmonkeyserummay be virus neutralizing in vitro when the actively immunized animals yielding it are incapable of withstanding an intracerebral injection of a highly potent virus. This experimental discrepancy between the in vivo and in vitro inactivating power of immune sera is instructive in that it not only indicates quantitative variations in immune power, but suggests that human beings also may yield neutralizing serum without themselves being completely or enduringly protected against the pathogenic action of a highly infectious virus strain.
In order to decide whether or not quantitative differences in various immune sera actually existed, a simple experiment was carried out. Monkeys which had recovered from typical poliomyelitis were repeatedly reinoculated with large amounts of active poliomyelitis virus, and the neutralizing value of serum obtained before and after the treatments was determined. The details of the experiment are as follows:
Reinforcement.--Six Macacus rhesus monkeys, which had survived typical attacks of experimental poliomyelitis and still showed residual paralyses 15 to 19 months after the original inoculation, were selected. Each was bled 20 cc., and the serum from the individual bleedings was separated in the usual manner. The several sera were pooled, and the resulting mixture was stored, unpreserved by Chemicals, at 4°C. The "reinforcing" injections were begun immediately after the first bleeding and conducted in the following manner. A 5 per cent suspension of glycerolated nervous tissue of the "pooled mixed" virus strain was (2) had shown that route to be more effective than subcutaneous inoculation for giving rise to an active immunity in monkeys. 15 cc. of the material was introduced in each set of injections by forming multiple superficial blebs. The treatments were repeated 10 times at 3 day intervals. Thus a total of 150 cc. of virus was given in 30 days. After a rest period of 1 month, the animals were bled, and the serum was separated, pooled, and stored as before. The monkeys were carefully observed to detect any evidence of recurring symptoms durin~the injections, and none whatever was seen. The technique of reinforcement is summarized in Table I .
Neutralization before Rei~forcement.--In determining the effectiveness of the serum, the usual in vitro technique was employed. The fresh Berkefeld filtrate virus was mixed with the serum to be tested, kept an hour at 20°C., and inoculated intracerebrally into normal monkeys of approximately the same size.
Tables II and III are consistent in showing that, given a constant potent virus filtrate used in amounts of 0.12 cc., the pooled convalescent monkey serum before reinforcement was ineffective in quantities less than 0.75 to 1 cc. A sample of pooled human convalescent serum in a volume of 0.1 cc. neutralized effectively in one test (Table III) .
Although the meaning of the test is not at once clear, it is well worth recording that in two instances a single sample of a human serum, taken from a child 8 years old who had never shown clinical evidence Neutralization after Reinforcement.-- Table IV , which includes three separate tests made on different dates, presents clear evidence that the pooled reinforced serum contained greater quantities of neutralizing antibodies than did the original pooled convalescent serum from the same monkeys. The fact is even more striking in that, so far as the tests were carried, there is clear indication that the reinforced serum possessed neutralizing value equal to that of pooled convalescent human serum. A discrepancy will be noted between the series of animals inoculated March 5, 1930, and the experiment summarized in Table III ; in the former instance 0.5 and 0.25 cc. of Typical polio-7 days myelitis non-reinforced serum protected against 0.12 cc. of virus filtrate, although 0.1 cc. failed to do so. The probable reason for this difference is to be found in the virus filtrate. A degree of inconstancy is encountered even in dealing with the most highly potent virus strains, for which adequate explanation is not at hand. The filtrate prepared from an occasional monkey, sacrificed promptly after the appearance of paralytic symptoms, proves somewhat less. active than the rule. Whether the fault is due to the quantity of virus units in the nervous system of a particular animal, or is influenced adversely by the operation of extracting it, is not known. On the whole, however, this series of experiments was remarkably regular. ).I There is a practical side to these observations. Hereafter in testing the prophylactic and therapeutic value of convalescent monkey serum for the purpose of securing indications of the value of convalescent human serum, either as a prophylactic or therapeutic measure, it may be desirable to employ not merely convalescent, but reinforced convalescent monkey serum. If sertun from actively immunized monkeys is also employed, preliminary tests of neutralizing power are desirable. Undoubtedly certain discrepancies and failures of experiments are traceable to the use of weak convalescent monkey serum instead of the stronger human convalescent serum. For experiments on monkeys the homologous reinforced monkey serum may be desirable. SUM~4~RY A comparison has been made of the neutralizing value of pooled convalescent monkey serum for the filtered virus of poliomyelitis, before and after a series of reinforcement injections of the same virus strain.
The strength of the pooled convalescent serum is increased by the reinforcing procedure.
The original monkey convalescent serum had a neutralization value much below that of a pooled human convalescent serum. By reinforcement the neutralization value of the monkey serum was brought approximately to that of the human serum.
One sample of serum from a supposedly normal child of 8 years exhibited a neutralizing value approximately equal to that of a pooled human convalescent serum and the reinforced pooled monkey serum.
BIBLIOGRAPHY
